Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 2,425 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Learning Disorders Clear all

Conditions: Down Syndrome
Interventions: Memantine, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 32 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Autism Spectrum Disorder
Interventions: STEPS; Behavioral
Lead sponsor: University of Alabama, Tuscaloosa; Other
Eligibility: 16 Years to 25 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Healthy Volunteer Study, Healthy Adults, Healthy Participants, Asthma
Interventions: PF-08103402, Placebo, Midazolam; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 133 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Overdose, Opioid Use Disorder, HIV Infections
Interventions: Overdose Education and Naloxone Distribution, Advanced Education in Safer Substance Use, Treatment, and Self-Care, Social Service and Health Navigation, Peer Social Support; Behavioral
Lead sponsor: New York University; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Opiod Use Disorder
Interventions: OUD screening, MOUD, Continuity of care; Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 16 Years and older
Enrollment: 271,031 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Improving Blood Pressure Control
Interventions: CONTROL- Usual & Customary Health Fair Follow-up, Health Fair + TECH [Text Messaging + Home Blood Pressure Monitoring], Heal th Fair + TECH [Text Messaging + Home Blood Pressure Monitoring] + Social Network Support (SNS); Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years and older · Male only
Enrollment: 166 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid-Related Disorders, Drug Addiction
Interventions: Not listed
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 21 Years to 60 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Alpha1-Antitrypsin Deficiency
Interventions: Fazirsiran Injection, Placebo; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 20
States / cities: Phoenix, Arizona • Tucson, Arizona • La Jolla, California + 15 more

Conditions: Stroke
Interventions: anodal transcranial direct current stimulation (a-tDCS); Combination Product
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 21 Years to 90 Years
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Obstructive Sleep Apnea
Interventions: Telemedicine Education, IVR; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 1,873 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Fontana, California

Conditions: Relapsing-Remitting Multiple Sclerosis
Interventions: Donepezil HCI (drug); Drug
Lead sponsor: Neurognostics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Muscular Atrophy, Spinal
Interventions: Nusinersen; Drug
Lead sponsor: Biogen; Industry
Eligibility: 2 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 7
States / cities: Sacramento, California • Aurora, Colorado • Chicago, Illinois + 4 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Project Dulce + Dulce Digital; Behavioral
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: El Cajon, California • Denver, Colorado

Conditions: Tinnitus
Interventions: Progressive Tinnitus Management, Wait List Control; Procedure
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 3
States / cities: West Haven, Connecticut • Portland, Oregon • Memphis, Tennessee

Conditions: Advanced Solid Tumors
Interventions: BAY2416964, Pembrolizumab; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Altamonte Springs, Florida • Sarasota, Florida • Detroit, Michigan + 3 more

Conditions: Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy
Interventions: Observational; Other
Lead sponsor: Columbia University; Other
Eligibility: 5 Years and older
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Leg Injury
Interventions: Psychologically Informed Education Video Series, Anatomy and biomedical education videos; Other
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 12 Years to 18 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Conduct Disorder, Oppositional Defiant Disorder, Attention Deficit Disorder With Hyperactivity
Interventions: Community mental health consultation model program, Treatment as usual (TAU); Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 5 Years to 12 Years
Enrollment: 482 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Pancreatic Cancer
Interventions: Coaching Sessions; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Type1diabetes
Interventions: Diabetes Education, T1DES; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 30 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Alzheimer Disease
Interventions: Perturbation training; Behavioral
Lead sponsor: Georgia State University; Other
Eligibility: 65 Years to 90 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Valdosta, Georgia

Conditions: Cognition, Cancer
Interventions: Emerging from the Haze; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Physical Activity
Interventions: Exercise Prescription; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Warrensville Heights, Ohio

Conditions: Opioid Overdose
Interventions: Enhanced Overdose Education (EOE), Standard education; Behavioral
Lead sponsor: Hartford Hospital; Other
Eligibility: 21 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Hartford, Connecticut

Search by objective public record fields.

Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome

Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Community-based Education, Navigation, and Support Intervention for Military Veterans

Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System

Taxi METERS: Measuring Effectiveness of Technology, Education, Referrals and Support

Outcome Inference in the Sensory Preconditioning Task in Opioid-Use Disorder

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

Explore the Effects of Cortical Priming on Visuomotor Stepping Learning in Persons With Chronic Stroke

Impact of Automated Education and Follow-up Mechanisms on Patient Engagement

A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties

A Study to Learn About the Long-Term Safety of Higher Doses of Nusinersen (BIIB058) Given as Injections to Participants With Spinal Muscular Atrophy (SMA) Who Took Part in an Earlier Nusinersen Trial (ONWARD)

Project Dulce for Arab Americans With Type 2 Diabetes

Multi-Site Evaluation of Progressive Tinnitus Management

A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults

Wearable Technology to Assess Gait Function in SMA and DMD

Psychologically Informed Education Intervention for Adolescents With Atraumatic Lower-Extremity Injuries

School-Based Mental Health Services for Urban Children

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

Type 1 Diabetes Education and Support Study

Perturbation Training Reduces Falls in People With Alzheimer's Disease (AD)

Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

Bridging Resources Improve the Development of Guideline-based Exercise

Improving Availability of Intranasal Naloxone